{"id":"cebc1a996b8d","type":"article","url":"https://hartvaat.nl/2025/01/01/hartfalenpreventie-bewijsgeneratie-trialontwerp-en-regulatoire-trajecten/","title":"Hartfalenpreventie: bewijsgeneratie, trialontwerp en regulatoire trajecten","title_en":"Heart Failure Prevention: Evidence Generation, Trial Design, and Regulatory Pathways","category":"algemeen","category_label":"Algemeen","professions":["cardioloog","huisarts"],"tags":[],"journal":"JACC","doi":"https://www.sciencedirect.com/science/article/pii/S0735109725105603?dgcid=rss_sd_all","source_url":"https://doi.org/https://www.sciencedirect.com/science/article/pii/S0735109725105603?dgcid=rss_sd_all","authors":["Javed Butler","Muhammad Shahzeb Khan","João Pedro Ferreira","Nicolas Girerd","Martha Gulati","Anuradha Lala","Mark C. Petrie","Norman Stockbridge","Muthiah Vaduganathan","Faiez Zannad"],"significance":7,"published":"2026-03-01","source_date":"2025-01-01","image":"","kennis":[],"congress":"","summary_en":"This JACC review discussed the current landscape of heart failure prevention, addressing evidence generation, clinical trial design challenges, and regulatory pathways for therapies aimed at preventing rather than treating established heart failure.","created":"2026-07-03T10:25:47Z","updated":"2026-07-03T13:25:10Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Beschouwing over de huidige stand van hartfalenpreventie, met aandacht voor bewijsgeneratie, klinisch trialontwerp en regulatoire goedkeuringstrajecten.","abstract_original":"Publication date: 21 April 2026Source: JACC, Volume 87, Issue 15"}